The MIROCALS (Modifying Immune Response and Outcomes in ALS) Clinical Trial is still on-going, with recruitment continuing until the end of September 2019.
Clinical trials are expensive to run and with several more neurology clinics taking part, ...
Read more: Charities and Patient Associations rally around MIROCALS to show their support
People with ALS participating in MIROCALS have agreed to be in an additional study
Read more: Neuroimaging delves deeper into brain changes in ALS
As with everything else affected by Brexit, there are probably more questions than answers!
Mid-February a webinar promoted awareness of ALS and the MIROCALS trials
The MIROCALS (Modifying Immune Response and Outcomes in ALS) Clinical Trial is still on-going, with recruitment continuing until the end of September 2019.
Read moreClinical trials are expensive to run and with several more neurology clinics taking part, ...
Read moreAs with everything else affected by Brexit, there are probably more questions than answers!
Read more
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 633413.